Award
National Cancer Institute 5R01CA276279-04
The Role of Egfl6 in Tumor Immunity
Recipient
Magee-Women's Res Inst and Foundation
Award Amount
$311,352.00
Ceiling
$311,352.00
Awarded
May 27, 2026
Identifier
5R01CA276279-04
Research project funded by the National Cancer Institute to study the role of Egfl6 in tumor immunity and improve immune checkpoint inhibitor therapy in ovarian cancer.
Description
This project aims to evaluate the role of Egfl6 in tumor immune suppression and to test the efficacy of Egfl6 neutralizing antibodies to enhance immune checkpoint inhibitor therapy in ovarian cancer.